|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Nov 17 | Buy | 1.68 | 15,000 | 25,200 | 123,945 | Nov 21 08:11 PM |
OMER | Demopulos Gregory A MD | CHAIRMAN, CEO & PRESIDENT | Jun 15 | Option Exercise | 4.10 | 36,856 | 151,110 | 2,063,842 | Jun 17 08:30 PM |
OMER | Demopulos Gregory A MD | CHAIRMAN, CEO & PRESIDENT | Jun 17 | Option Exercise | 4.10 | 36,857 | 151,114 | 2,063,843 | Jun 17 08:30 PM |
OMER | Demopulos Gregory A MD | CHAIRMAN, CEO & PRESIDENT | Jun 17 | Sale | 14.90 | 36,857 | 549,169 | 2,026,986 | Jun 17 08:30 PM |
OMER | Demopulos Gregory A MD | CHAIRMAN, CEO & PRESIDENT | Jun 15 | Sale | 15.02 | 36,856 | 553,577 | 2,026,986 | Jun 17 08:30 PM |
OMER | Demopulos Gregory A MD | CHAIRMAN, CEO & PRESIDENT | Apr 07 | Option Exercise | 4.10 | 37,407 | 153,369 | 2,064,393 | Apr 08 07:52 PM |
OMER | Demopulos Gregory A MD | CHAIRMAN, CEO & PRESIDENT | Apr 08 | Option Exercise | 4.10 | 35,206 | 144,345 | 2,062,192 | Apr 08 07:52 PM |
OMER | Demopulos Gregory A MD | CHAIRMAN, CEO & PRESIDENT | Apr 08 | Sale | 17.76 | 35,206 | 625,259 | 2,026,986 | Apr 08 07:52 PM |
OMER | Demopulos Gregory A MD | CHAIRMAN, CEO & PRESIDENT | Apr 07 | Sale | 17.91 | 37,407 | 669,959 | 2,026,986 | Apr 08 07:52 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Dec 28 | Option Exercise | 2.91 | 142,001 | 413,838 | 2,026,986 | Dec 28 06:45 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Dec 05 | Option Exercise | 0.98 | 102,040 | 99,999 | 1,987,025 | Dec 07 09:00 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Dec 06 | Option Exercise | 0.98 | 102,040 | 99,999 | 1,987,025 | Dec 07 09:00 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Dec 07 | Option Exercise | 0.98 | 102,044 | 100,003 | 1,987,029 | Dec 07 09:00 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Dec 07 | Sale | 10.48 | 102,044 | 1,069,033 | 1,884,985 | Dec 07 09:00 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Dec 06 | Sale | 10.80 | 102,040 | 1,101,808 | 1,884,985 | Dec 07 09:00 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Dec 05 | Sale | 10.71 | 102,040 | 1,092,644 | 1,884,985 | Dec 07 09:00 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Nov 30 | Option Exercise | 0.98 | 97,559 | 95,608 | 1,801,381 | Dec 02 09:40 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Dec 01 | Option Exercise | 0.98 | 106,521 | 104,391 | 1,810,343 | Dec 02 09:40 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Dec 02 | Option Exercise | 0.98 | 283,203 | 277,539 | 1,884,985 | Dec 02 09:40 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Dec 02 | Sale | 11.00 | 102,040 | 1,122,593 | 1,703,822 | Dec 02 09:40 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Dec 01 | Sale | 11.57 | 106,521 | 1,232,063 | 1,703,822 | Dec 02 09:40 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Nov 30 | Sale | 12.21 | 97,559 | 1,191,478 | 1,703,822 | Dec 02 09:40 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Jan 14 | Option Exercise | 0.98 | 100,000 | 98,000 | 1,703,822 | Jan 15 07:00 AM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Aug 18 | Option Exercise | 0.98 | 12,000 | 11,760 | 1,603,822 | Aug 20 08:00 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Jan 28 | Option Exercise | 0.98 | 32,000 | 31,360 | 1,591,822 | Jan 29 09:00 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | Nov 02 | Option Exercise | 0.98 | 33,000 | 32,340 | 1,559,822 | Nov 04 08:00 PM |
OMER | Demopulos Gregory A MD | Chairman, CEO & President | May 18 | Option Exercise | 0.98 | 20,000 | 19,600 | 1,526,822 | May 19 05:49 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite